Skip to main content
European Commission logo
Public Health

The Health Equity Programme: Hepatitis Outreach for Migrant Populations

Migrants and refugees in Europe often struggle to access viral hepatitis (HBV and HCV) prevention, screening, and care, often leading to late diagnosis, worse health outcomes, and a higher burden of liver disease. These barriers, often systemic and sociocultural in nature, are compounded by the infections' silent nature. The Health Equity Program: Hepatitis Outreach for Migrant Populations (HEP-HOP) project aims to overcome these barriers by improving, scaling up, and evaluating community-based programmes for viral hepatitis screening, HBV vaccination, and linkage to care. A critical focus will be on understanding and tackling vaccine misinformation, disinformation, and hesitancy among at-risk migrant and refugee populations in Belgium, Latvia, and Spain to support HBV vaccination uptake.

The specific objectives of the HEP-HOP project include:

  1. Expand access to decentralised services by implementing and evaluating community-based screening and vaccination programs;
  2. Enhance linkage to care by increasing the number of people living with viral hepatitis who are screened, diagnosed, and linked to care;
  3. Decrease HBV vaccination hesitancy by addressing vaccine mis/disinformation and increasing health literacy levels;
  4. Strengthen health system capacity by training community health workers (CHWs) and non-healthcare personnel (e.g., community teachers) to deliver viral hepatitis services and combat vaccine mis/disinformation;
  5. Evaluate impact and disseminate best practices by conducting evaluations to measure interventions’ impact; and,
  6. Share findings to inform future policies and programs across Europe

Results

  • Increased rates of HBV and HCV screening and diagnosis among migrants and refugees through the implementation of community-based, culturally tailored interventions.
  • Increased HBV vaccination uptake by addressing vaccine hesitancy, mis/disinformation and barriers, through targeted education campaigns and system-level collaborations.
  • Enhanced linkage to care and treatment for viral hepatitis infections, resulting in improved liver health outcomes, including impact on liver cancer incidence.
  • A culturally appropriate training curriculum for community health and lay workers that can be used in other European settings.
  • A reduction in vaccine mis-and disinformation and vaccine hesitancy among migrant and refugee populations in Spain and Belgium.
  • Increased cross-border cooperation and collective learning to address a shared public health concern and sustainable collaboration across Europe to advance towards improved health and quality of life for all.

Stakeholders

Coordinators

Contact

Dr Camila Picchio

Name
Dr Camila Picchio
Organisation
Barcelona Institute for Global Health (ISGlobal)
Website
https://www.isglobal.org/en/our-team/-/profiles/21702
Email
camila [dot] picchioatisglobal [dot] org

Prof Jeffrey V Lazarus

Name
Prof Jeffrey V Lazarus
Organisation
Barcelona Institute for Global Health (ISGlobal)
Website
https://www.isglobal.org/en/our-team/-/profiles/12802
Email
Jeffrey [dot] lazarusatisglobal [dot] org